| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.689 | 0.004 | 0.689 | Psychostimulant | 0.469 0.014 DBMET00378 | ||
| 0.585 | 0.004 | 0.585 | 5 Hydroxytryptamine uptake inhibitor | 0.515 0.004 DBMET00378 | ||
| 0.558 | 0.002 | 0.558 | Dopamine transporter inhibitor | 0.47 0.003 DBMET00378 | ||
| 0.56 | 0.011 | 0.56 | Antiamyloidogenic | 0.396 0.029 DBMET00378 | ||
| 0.542 | 0.029 | 0.542 | Antiobesity | 0.542 0.029 DBMET00378 | ||
| 0.435 | 0.03 | 0.435 | Nootropic | 0.211 0.144 DBMET00378 | ||
| 0.377 | 0.028 | 0.594 | Nitric oxide antagonist | 0.594 0.01 DBMET00378 | DBMET00378 | |
| 0.305 | 0.004 | 0.362 | Interleukin 5 antagonist | 0.362 0.004 DBMET00378 | DBMET00378 | |
| 0.323 | 0.043 | 0.323 | Interleukin antagonist | 0.281 0.052 DBMET00378 | ||
| 0.348 | 0.077 | 0.348 | Thioredoxin glutathione reductase inhibitor | 0.311 0.096 DBMET00378 | ||
| 0.282 | 0.07 | 0.282 | Insulysin inhibitor | 0.225 0.122 DBMET00378 | ||
| 0.216 | 0.005 | 0.216 | Dopamine uptake inhibitor | 0.146 0.01 DBMET00378 | ||
| 0.232 | 0.029 | 0.232 | Phospholipase A2 inhibitor | 0.218 0.034 DBMET00378 | ||
| 0.193 | 0.014 | 0.193 | Gastric antisecretory | 0.141 0.031 DBMET00378 | ||
| 0.187 | 0.01 | 0.187 | Alpha adrenoreceptor agonist | 0.06 0.055 DBMET00378 | ||
| 0.213 | 0.039 | 0.279 | Succinate dehydrogenase inhibitor | 0.279 0.014 DBMET00378 | DBMET00378 | |
| 0.19 | 0.025 | 0.217 | Ferrochelatase inhibitor | 0.217 0.019 DBMET00378 | DBMET00378 | |
| 0.218 | 0.054 | 0.366 | Peroxidase inhibitor | 0.366 0.026 DBMET00378 | DBMET00378 | |
| 0.24 | 0.081 | 0.327 | Superoxide dismutase inhibitor | 0.327 0.042 DBMET00378 | DBMET00378 | |
| 0.23 | 0.076 | 0.23 | Neuropeptide Y2 antagonist | 0.183 0.153 DBMET00378 | ||
| 0.15 | 0.002 | 0.15 | GABA uptake inhibitor | 0.143 0.002 DBMET00378 | ||
| 0.236 | 0.096 | 0.258 | 5 Hydroxytryptamine uptake stimulant | 0.258 0.073 DBMET00378 | DBMET00378 | |
| 0.148 | 0.009 | 0.148 | Adrenaline uptake inhibitor | 0.096 0.02 DBMET00378 | ||
| 0.147 | 0.012 | 0.281 | Phenylalanine 4-hydroxylase inhibitor | 0.281 0.004 DBMET00378 | DBMET00378 | |
| 0.144 | 0.01 | 0.144 | Alpha 1 adrenoreceptor agonist | 0.052 0.048 DBMET00378 | ||
| 0.227 | 0.094 | 0.285 | Tyrosine 3 hydroxylase inhibitor | 0.285 0.041 DBMET00378 | DBMET00378 | |
| 0.162 | 0.031 | 0.162 | Calcium channel N-type blocker | 0.129 0.053 DBMET00378 | ||
| 0.146 | 0.015 | 0.146 | Adrenaline agonist | 0.103 0.035 DBMET00378 | ||
| 0.187 | 0.064 | 0.187 | Growth hormone agonist | 0.148 0.089 DBMET00378 | ||
| 0.218 | 0.096 | 0.572 | Aldehyde oxidase inhibitor | 0.572 0.023 DBMET00378 | DBMET00378 | |
| 0.152 | 0.037 | 0.22 | Aminopeptidase B inhibitor | 0.22 0.017 DBMET00378 | DBMET00378 | |
| 0.311 | 0.198 | 0.311 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.129 | 0.018 | 0.235 | Glutamate decarboxylase inhibitor | 0.235 0.005 DBMET00378 | DBMET00378 | |
| 0.158 | 0.05 | 0.357 | Alpha-N-acetylglucosaminidase inhibitor | 0.357 0.011 DBMET00378 | DBMET00378 | |
| 0.202 | 0.096 | 0.216 | Peptidyltransferase inhibitor | 0.216 0.08 DBMET00378 | DBMET00378 | |
| 0.189 | 0.084 | 0.189 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.113 | 0.009 | 0.132 | GABA B receptor agonist | 0.132 0.005 DBMET00378 | DBMET00378 | |
| 0.122 | 0.019 | 0.138 | Aminopeptidase I inhibitor | 0.138 0.015 DBMET00378 | DBMET00378 | |
| 0.108 | 0.006 | 0.108 | Exportin-1 inhibitor | 0.084 0.02 DBMET00378 | ||
| 0.14 | 0.039 | 0.246 | Mucolytic | 0.246 0.007 DBMET00378 | DBMET00378 | |
| 0.153 | 0.056 | 0.153 | Calcium channel blocker | 0.15 0.059 DBMET00378 | ||
| 0.129 | 0.035 | 0.152 | Creatine kinase inhibitor | 0.152 0.023 DBMET00378 | DBMET00378 | |
| 0.131 | 0.043 | 0.252 | GABA C receptor agonist | 0.252 0.013 DBMET00378 | DBMET00378 | |
| 0.11 | 0.026 | 0.149 | Glutamate dehydrogenase inhibitor | 0.149 0.016 DBMET00378 | DBMET00378 | |
| 0.128 | 0.049 | 0.128 | Calcium channel (voltage-sensitive) blocker | 0.122 0.054 DBMET00378 | ||
| 0.118 | 0.04 | 0.167 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.167 0.022 DBMET00378 | DBMET00378 | |
| 0.113 | 0.037 | 0.176 | Triose-phosphate isomerase inhibitor | 0.176 0.014 DBMET00378 | DBMET00378 | |
| 0.122 | 0.05 | 0.145 | GABA C receptor antagonist | 0.145 0.033 DBMET00378 | DBMET00378 | |
| 0.09 | 0.019 | 0.096 | Acyl-CoA dehydrogenase inhibitor | 0.096 0.017 DBMET00378 | DBMET00378 | |
| 0.091 | 0.02 | 0.091 | Protease 3C (Human rhinovirus) inhibitor | 0.061 0.051 DBMET00378 | ||
| 0.117 | 0.046 | 0.19 | Adenylate kinase inhibitor | 0.19 0.016 DBMET00378 | DBMET00378 | |
| 0.073 | 0.009 | 0.073 | Histamine H2 receptor agonist | |||
| 0.069 | 0.012 | 0.069 | Immunoglobulin Fc receptor antagonist | |||
| 0.07 | 0.017 | 0.07 | H+/K+-transporting ATPase inhibitor | 0.066 0.02 DBMET00378 | ||
| 0.092 | 0.04 | 0.153 | Porphobilinogen synthase inhibitor | 0.153 0.02 DBMET00378 | DBMET00378 | |
| 0.078 | 0.027 | 0.099 | Biliverdin reductase inhibitor | 0.099 0.019 DBMET00378 | DBMET00378 | |
| 0.199 | 0.15 | 0.301 | Gastrin inhibitor | 0.301 0.032 DBMET00378 | DBMET00378 | |
| 0.107 | 0.061 | 0.246 | Expectorant | 0.246 0.013 DBMET00378 | DBMET00378 | |
| 0.117 | 0.074 | 0.175 | Aldehyde dehydrogenase inhibitor | 0.175 0.035 DBMET00378 | DBMET00378 | |
| 0.096 | 0.057 | 0.124 | Alcohol dehydrogenase inhibitor | 0.124 0.032 DBMET00378 | DBMET00378 | |
| 0.051 | 0.013 | 0.499 | Prostacyclin antagonist | 0.499 0.002 DBMET00378 | DBMET00378 | |
| 0.113 | 0.076 | 0.113 | Histone deacetylase class III inhibitor | |||
| 0.099 | 0.063 | 0.099 | Carbonic anhydrase III inhibitor | 0.088 0.078 DBMET00378 | ||
| 0.069 | 0.035 | 0.127 | Carbamoyl phosphate synthetase inhibitor | 0.127 0.014 DBMET00378 | DBMET00378 | |
| 0.217 | 0.189 | 0.278 | Calcium channel activator | 0.278 0.115 DBMET00378 | DBMET00378 | |
| 0.215 | 0.189 | 0.237 | GABA C receptor rho-3 antagonist | 0.237 0.167 DBMET00378 | DBMET00378 | |
| 0.058 | 0.033 | 0.077 | Ornithine carbamoyltransferase inhibitor | 0.077 0.023 DBMET00378 | DBMET00378 | |
| 0.06 | 0.035 | 0.09 | Alcohol oxidase inhibitor | 0.09 0.021 DBMET00378 | DBMET00378 | |
| 0.042 | 0.019 | 0.065 | Glutamate (mGluR8) agonist | 0.065 0.006 DBMET00378 | DBMET00378 | |
| 0.082 | 0.061 | 0.082 | Histamine H2 receptor antagonist | |||
| 0.026 | 0.005 | 0.026 | Carbonic anhydrase X inhibitor | 0.019 0.009 DBMET00378 | ||
| 0.026 | 0.005 | 0.026 | Carbonic anhydrase VIII inhibitor | 0.019 0.009 DBMET00378 | ||
| 0.045 | 0.027 | 0.045 | Oxytocin agonist | |||
| 0.041 | 0.025 | 0.054 | Membrane dipeptidase inhibitor | 0.054 0.013 DBMET00378 | DBMET00378 | |
| 0.113 | 0.1 | 0.113 | Histone deacetylase SIRT1 inhibitor | |||
| 0.02 | 0.008 | 0.024 | Methylmalonyl-CoA mutase inhibitor | 0.024 0.004 DBMET00378 | DBMET00378 | |
| 0.068 | 0.056 | 0.118 | Catalase inhibitor | 0.118 0.033 DBMET00378 | DBMET00378 | |
| 0.263 | 0.252 | 0.743 | Antiinflammatory | 0.743 0.023 DBMET00378 | DBMET00378 | |
| 0.139 | 0.131 | 0.191 | Phospholipase C inhibitor | 0.191 0.05 DBMET00378 | DBMET00378 | |
| 0.066 | 0.059 | 0.077 | Lipase inhibitor | 0.077 0.047 DBMET00378 | DBMET00378 | |
| 0.036 | 0.029 | 0.036 | Somatostatin 1 antagonist | |||
| 0.063 | 0.057 | 0.087 | Glutamate (mGluR6) antagonist | 0.087 0.018 DBMET00378 | DBMET00378 | |
| 0.024 | 0.02 | 0.144 | Leukotriene D4 antagonist | 0.144 0.005 DBMET00378 | DBMET00378 | |
| 0.012 | 0.01 | 0.012 | Carbonic anhydrase XI inhibitor | |||
| 0.049 | 0.048 | 0.049 | Aminopeptidase microsomal inhibitor | |||
| 0.105 | 0.106 | 0.112 | Sphingosine 1-phosphate receptor 4 antagonist | 0.112 0.09 DBMET00378 | DBMET00378 | |
| 0.048 | 0.049 | 0.061 | Alpha-mannosidase inhibitor | 0.061 0.026 DBMET00378 | DBMET00378 | |
| 0.015 | 0.016 | 0.017 | Aminopeptidase A inhibitor | 0.017 0.013 DBMET00378 | DBMET00378 | |
| 0.018 | 0.023 | 0.025 | Glutamate (mGluR1a) agonist | 0.025 0.012 DBMET00378 | DBMET00378 | |
| 0.044 | 0.05 | 0.101 | Aconitate hydratase inhibitor | 0.101 0.008 DBMET00378 | DBMET00378 | |
| 0.12 | 0.125 | 0.146 | Sphingosine 1-phosphate receptor 5 antagonist | 0.146 0.069 DBMET00378 | DBMET00378 | |
| 0.081 | 0.087 | 0.119 | UDP-glucose 4-epimerase inhibitor | 0.119 0.044 DBMET00378 | DBMET00378 | |
| 0.028 | 0.036 | 0.039 | Glutamate (mGluR3) agonist | 0.039 0.01 DBMET00378 | DBMET00378 | |
| 0.037 | 0.045 | 0.051 | Mannosidase inhibitor | 0.051 0.024 DBMET00378 | DBMET00378 | |
| 0.019 | 0.029 | 0.026 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.026 0.021 DBMET00378 | DBMET00378 | |
| 0.026 | 0.037 | 0.041 | Fumarate hydratase inhibitor | 0.041 0.018 DBMET00378 | DBMET00378 | |
| 0.051 | 0.065 | 0.067 | NMDA receptor agonist | 0.067 0.039 DBMET00378 | DBMET00378 | |
| 0.051 | 0.066 | 0.147 | Leukotriene antagonist | 0.147 0.01 DBMET00378 | DBMET00378 | |
| 0.007 | 0.023 | 0.013 | Glutamate (mGluR6) agonist | 0.013 0.007 DBMET00378 | DBMET00378 | |
| 0.018 | 0.035 | 0.031 | Lysine carboxypeptidase inhibitor | 0.031 0.015 DBMET00378 | DBMET00378 | |
| 0.045 | 0.069 | 0.245 | DNA helicase inhibitor | 0.245 0.002 DBMET00378 | DBMET00378 | |
| 0.072 | 0.097 | 0.082 | D-Ala-D-Ala ligase inhibitor | 0.082 0.062 DBMET00378 | DBMET00378 | |
| 0.071 | 0.099 | 0.118 | NADH dehydrogenase inhibitor | 0.118 0.029 DBMET00378 | DBMET00378 | |
| 0.043 | 0.072 | 0.06 | Angiotensin-converting enzyme inhibitor | 0.06 0.03 DBMET00378 | DBMET00378 | |
| 0.046 | 0.076 | 0.125 | Phosphofructokinase-1 inhibitor | 0.125 0.024 DBMET00378 | DBMET00378 | |
| 0.124 | 0.155 | 0.15 | Ca2+-transporting ATPase inhibitor | 0.15 0.043 DBMET00378 | DBMET00378 | |
| 0.032 | 0.063 | 0.039 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.039 0.035 DBMET00378 | DBMET00378 | |
| 0.084 | 0.115 | 0.115 | DOPA decarboxylase inhibitor | 0.115 0.05 DBMET00378 | DBMET00378 | |
| 0.039 | 0.071 | 0.052 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.052 0.04 DBMET00378 | DBMET00378 | |
| 0.048 | 0.084 | 0.093 | Histidine decarboxylase inhibitor | 0.093 0.035 DBMET00378 | DBMET00378 | |
| 0.028 | 0.066 | 0.155 | Thromboxane A2 antagonist | 0.155 0.004 DBMET00378 | DBMET00378 | |
| 0.031 | 0.071 | 0.044 | Kainate receptor agonist | 0.044 0.023 DBMET00378 | DBMET00378 | |
| 0.117 | 0.157 | 0.253 | DNA methylase inhibitor | 0.253 0.047 DBMET00378 | DBMET00378 | |
| 0.038 | 0.078 | 0.071 | Leukotriene B4 antagonist | 0.071 0.019 DBMET00378 | DBMET00378 | |
| 0.114 | 0.155 | 0.267 | DNA methyltransferase I inhibitor | 0.267 0.04 DBMET00378 | DBMET00378 | |
| 0.016 | 0.057 | 0.034 | Leukotriene A4 hydrolase inhibitor | 0.034 0.029 DBMET00378 | DBMET00378 | |
| 0.034 | 0.077 | 0.068 | Glucose-6-phosphate isomerase inhibitor | 0.068 0.014 DBMET00378 | DBMET00378 | |
| 0.063 | 0.106 | 0.092 | Glutathione S-transferase inhibitor | 0.092 0.045 DBMET00378 | DBMET00378 | |
| 0.029 | 0.077 | 0.162 | Thromboxane antagonist | 0.162 0.004 DBMET00378 | DBMET00378 | |
| 0.054 | 0.102 | 0.076 | Glycine receptor agonist | 0.076 0.043 DBMET00378 | DBMET00378 | |
| 0.114 | 0.163 | 0.191 | Hepatoprotectant | 0.191 0.071 DBMET00378 | DBMET00378 | |
| 0.071 | 0.123 | 0.147 | Electrolyte absorption antagonist | 0.147 0.02 DBMET00378 | DBMET00378 | |
| 0.101 | 0.154 | 0.123 | Sphingosine 1-phosphate receptor 2 antagonist | 0.123 0.088 DBMET00378 | DBMET00378 | |
| 0.032 | 0.087 | 0.066 | Argininosuccinate synthase inhibitor | 0.066 0.033 DBMET00378 | DBMET00378 | |
| 0.104 | 0.168 | 0.131 | Adenylate cyclase stimulant | 0.131 0.099 DBMET00378 | DBMET00378 | |
| 0.049 | 0.117 | 0.068 | GABA aminotransferase inhibitor | 0.068 0.065 DBMET00378 | DBMET00378 | |
| 0.036 | 0.105 | 0.074 | Thromboxane synthase inhibitor | 0.074 0.015 DBMET00378 | DBMET00378 | |
| 0.161 | 0.234 | 0.296 | Antithrombotic | 0.296 0.091 DBMET00378 | DBMET00378 | |
| 0.056 | 0.133 | 0.106 | HIV-1 integrase (Overall Integration) inhibitor | 0.106 0.049 DBMET00378 | DBMET00378 | |
| 0.063 | 0.144 | 0.094 | Anabolic | 0.094 0.071 DBMET00378 | DBMET00378 | |
| 0.031 | 0.113 | 0.054 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.054 0.042 DBMET00378 | DBMET00378 | |
| 0.009 | 0.094 | 0.041 | Leukotriene B4 receptor 1 antagonist | 0.041 0.011 DBMET00378 | DBMET00378 | |
| 0.018 | 0.106 | 0.141 | Macrophage elastase inhibitor | 0.141 0.006 DBMET00378 | DBMET00378 | |
| 0.036 | 0.127 | 0.062 | Purinergic P2X1 antagonist | 0.062 0.04 DBMET00378 | DBMET00378 | |
| 0.052 | 0.145 | 0.065 | MDM2 inhibitor | 0.065 0.056 DBMET00378 | DBMET00378 | |
| 0.163 | 0.258 | 0.317 | Histamine release inhibitor | 0.317 0.115 DBMET00378 | DBMET00378 | |
| 0.067 | 0.166 | 0.111 | Microtubule formation inhibitor | 0.111 0.073 DBMET00378 | DBMET00378 | |
| 0.086 | 0.192 | 0.182 | Arachidonic acid antagonist | 0.182 0.051 DBMET00378 | DBMET00378 | |
| 0.068 | 0.18 | 0.105 | Cyclooxygenase 3 inhibitor | 0.105 0.096 DBMET00378 | DBMET00378 | |
| 0.022 | 0.136 | 0.052 | Lysophosphatidic acid 3 receptor antagonist | 0.052 0.033 DBMET00378 | DBMET00378 | |
| 0.084 | 0.199 | 0.122 | Mannose-6-phosphate isomerase inhibitor | 0.122 0.097 DBMET00378 | DBMET00378 | |
| 0.021 | 0.146 | 0.036 | Glutamate (mGluR8) antagonist | 0.036 0.024 DBMET00378 | DBMET00378 | |
| 0.194 | 0.319 | 0.265 | 5 Hydroxytryptamine release inhibitor | 0.265 0.207 DBMET00378 | DBMET00378 | |
| 0.066 | 0.193 | 0.099 | Photosensitizer | 0.099 0.091 DBMET00378 | DBMET00378 | |
| 0.01 | 0.143 | 0.02 | Retinoid X beta receptor antagonist | 0.02 0.015 DBMET00378 | DBMET00378 | |
| 0.037 | 0.181 | 0.054 | Leukotriene C antagonist | 0.054 0.048 DBMET00378 | DBMET00378 | |
| 0.004 | 0.148 | 0.031 | Prostaglandin H2 antagonist | 0.031 0.013 DBMET00378 | DBMET00378 | |
| 0.004 | 0.151 | 0.017 | Prostacyclin agonist | 0.017 0.01 DBMET00378 | DBMET00378 | |
| 0.047 | 0.202 | 0.112 | Cystathionine beta-synthase inhibitor | 0.112 0.064 DBMET00378 | DBMET00378 | |
| 0.024 | 0.19 | 0.126 | Leukotriene synthesis inhibitor | 0.126 0.014 DBMET00378 | DBMET00378 | |
| 0.083 | 0.249 | 0.127 | Melanin inhibitor | 0.127 0.12 DBMET00378 | DBMET00378 | |
| 0.017 | 0.192 | 0.036 | Retinoid X receptor antagonist | 0.036 0.03 DBMET00378 | DBMET00378 | |
| 0.006 | 0.185 | 0.054 | Prostaglandin agonist | 0.054 0.009 DBMET00378 | DBMET00378 | |
| 0.045 | 0.228 | 0.091 | Bile acid receptor antagonist | 0.091 0.072 DBMET00378 | DBMET00378 | |
| 0.005 | 0.242 | 0.044 | Urate transporter 1 inhibitor | 0.044 0.023 DBMET00378 | DBMET00378 | |
| 0.035 | 0.28 | 0.122 | M17 leucyl aminopeptidase inhibitor | 0.122 0.076 DBMET00378 | DBMET00378 | |
| 0.09 | 0.364 | 0.257 | Cholesterol antagonist | 0.257 0.12 DBMET00378 | DBMET00378 | |
| 0.006 | 0.288 | 0.214 | Prostaglandin D2 agonist | 0.214 0.002 DBMET00378 | DBMET00378 | |
| 0.113 | 0.42 | 0.197 | Interleukin 2 agonist | 0.197 0.194 DBMET00378 | DBMET00378 | |
| 0.046 | 0.389 | 0.474 | Platelet antagonist | 0.474 0.017 DBMET00378 | DBMET00378 | |
| 0.006 | 0.381 | 0.271 | Prostaglandin EP2 antagonist | 0.271 0.005 DBMET00378 | DBMET00378 | |
| 0.003 | 0.436 | 0.059 | Prostaglandin EP3 antagonist | 0.059 0.008 DBMET00378 | DBMET00378 | |
| 0.061 | 0.56 | 0.306 | Sodium/bile acid cotransporter inhibitor | 0.306 0.073 DBMET00378 | DBMET00378 | |
| 0.025 | 0.543 | 0.348 | Platelet aggregation inhibitor | 0.348 0.026 DBMET00378 | DBMET00378 | |
| 0.011 | 0.799 | 0.124 | Insulin secretagoues | 0.124 0.105 DBMET00378 | DBMET00378 | |
| 0.002 | 0.818 | 0.017 | Free fatty acid receptor 1 agonist | 0.017 0.012 DBMET00378 | DBMET00378 | |
| 0.005 | 0.902 | 0.149 | Uric acid excretion stimulant | 0.149 0.023 DBMET00378 | DBMET00378 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |